Medifocus Inc. Receivables Turnover Ratio (MDFZF), from the fourth quarter 2019 to the fourth quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Medifocus Inc.  (MDFZF)
 

Medifocus Accounts Receivables Turnover Ratio from the fourth quarter 2019 to the fourth quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Medifocus Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2019 to a ratio of 5.54, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the fourth quarter 2019. Average receivable collection period, for the Medifocus in Mar 31 2019 quarter, has decreased to 66 days, compared to 74 days, in the 0 quarter.

If we take a look into Healthcare sector 354 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2019 from to 2847.

What is Receivable Turnover Ratio?
What is Medifocus Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MDFZF Receivables Turnover Ratio (Mar 31 2019)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Mar 31 2018)
IV. Quarter
Y / Y Receivable Change -24.41 % -24.41 % -24.41 % -8.35 % -35.24 %
Y / Y Revenue Change 3.75 % - - - -41.19 %
Receivable Turnover Ratio (TTM) 5.54 4.94 4.6 4.3 4.22
MDFZF's Total Ranking # 2847 # # # # 3567
Accounts Receivable average collection period days 66 74 79 85 86
Seq. Receivable Change 0 % 0 % 0 % -24.41 % 0 %
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 111
Healthcare Sector # 355
Overall Market # 2847

Receivable Turnover Ratio Statistics
High Average Low
6.86 5.15 3.99
(Mar 31 2016)   (Mar 31 2015)





MDFZF Company Profile • Back to MDFZF Efficiency Comparisons • Compare MDFZF Receivables Turnover Ratio to its Competitors

Financial Statements
Medifocus's Accounts Receivable $ 0 Millions Visit MDFZF's Balance sheet
Medifocus's Sales TTM $ 3 Millions Visit MDFZF's Income Statement
Sources of MDFZF's Revenues Visit MDFZF's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MDFZF's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MDFZF's Growth Rates MDFZF's Roa MDFZF's Inventory Turnover Ratio MDFZF's Dividend Comparisons
MDFZF's Profitability Ratios MDFZF's Roi MDFZF's Asset Turnover Ratio MDFZF's Dividend Growth
MDFZF's Valuation Ratios MDFZF's Roe MDFZF's Financial Strength Ratios MDFZF's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2019 Receivable at quarter ending Mar 31 2019
Chimerix Inc   15.22 $ 8.774  Millions$ 0.577  Millions
Emmaus Life Sciences Inc   15.11 $ 1.581  Millions$ 0.105  Millions
Ainos Inc   14.99 $ 0.025  Millions$ 0.002  Millions
Akebia Therapeutics Inc   14.23 $ 234.478  Millions$ 16.480  Millions
Viskase Holdings inc   14.13 $ 6.852  Millions$ 0.485  Millions
Otonomy Inc   14.06 $ 0.636  Millions$ 0.045  Millions
Ibio inc   13.62 $ 1.314  Millions$ 0.097  Millions
Crh Medical Corporation  13.60 $ 197.931  Millions$ 14.558  Millions
Regeneron Pharmaceuticals Inc   13.13 $ 7,018.464  Millions$ 534.608  Millions
Organogenesis Holdings Inc   12.92 $ 215.043  Millions$ 16.647  Millions
Sangamo Therapeutics Inc   12.92 $ 79.886  Millions$ 6.186  Millions
Portola Pharmaceuticals inc   12.62 $ 55.655  Millions$ 4.409  Millions
Mannkind Corporation  12.51 $ 41.841  Millions$ 3.344  Millions
Travere Therapeutics Inc   12.48 $ 165.384  Millions$ 13.253  Millions
Silk Road Medical Inc   12.47 $ 12.766  Millions$ 1.024  Millions
H cyte Inc  12.43 $ 1.998  Millions$ 0.161  Millions
Dmk Pharmaceuticals Corporation  12.36 $ 16.813  Millions$ 1.360  Millions
Corcept Therapeutics Inc  12.18 $ 258.417  Millions$ 21.218  Millions
Scienture Holdings Inc   12.08 $ 4.491  Millions$ 0.372  Millions
Edesa Biotech Inc   12.05 $ 0.298  Millions$ 0.025  Millions
Neurometrix Inc   11.93 $ 14.270  Millions$ 1.196  Millions
Immucell Corporation  11.90 $ 12.067  Millions$ 1.014  Millions
Novaccess Global Inc  11.85 $ 1.397  Millions$ 0.118  Millions
Cytomx Therapeutics Inc   11.81 $ 74.803  Millions$ 6.334  Millions
Exact Sciences Corporation  11.79 $ 526.209  Millions$ 44.630  Millions
Integrated Biopharma Inc  11.76 $ 48.958  Millions$ 4.163  Millions
Zynex inc   11.71 $ 34.237  Millions$ 2.925  Millions
Teladoc Health Inc   11.59 $ 499.148  Millions$ 43.059  Millions
Lifeloc Technologies Inc   11.58 $ 8.305  Millions$ 0.717  Millions
Nuo Therapeutics Inc   11.56 $ 1.250  Millions$ 0.108  Millions

Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.